Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Obesity 1Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Inflammation 1Hodgkin Disease 1Frailty 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

epigallocatechin gallate 1cytisine 1Vitamin D 1Spirometry 1Selenium 1Resistance Training 1Probiotics 1Plastic Surgery Procedures 1Losartan 1Hematologic Tests 1Endurance Training 1Diet Therapy 1Calcium 1Aspirin 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammation × Ascorbic Acid × 90 days × Clear all
NCT04553666 2026-05-07

ReFOCUS1

University of Rochester

Phase 2 Completed
24 enrolled 17 charts

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡